Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

NCT02746991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

153

Enrollment

INDUSTRY

Sponsor class

Conditions

Posterior Uveitis
Intermediate Uveitis
Panuveitis

Interventions

DRUG: Sham Injection
DRUG: FAI Insert

Sponsor

EyePoint Pharmaceuticals, Inc.